U.S. flag

An official website of the United States government

NM_033337.3(CAV3):c.10_17del (p.Glu4fs) AND Cardiovascular phenotype

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Dec 16, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002436126.2

Allele description [Variation Report for NM_033337.3(CAV3):c.10_17del (p.Glu4fs)]

NM_033337.3(CAV3):c.10_17del (p.Glu4fs)

Gene:
CAV3:caveolin 3 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
3p25.3
Genomic location:
Preferred name:
NM_033337.3(CAV3):c.10_17del (p.Glu4fs)
HGVS:
  • NC_000003.12:g.8733886_8733893del
  • NG_008797.2:g.5077_5084del
  • NM_001234.5:c.10_17del
  • NM_033337.3:c.10_17delMANE SELECT
  • NP_001225.1:p.Glu4fs
  • NP_203123.1:p.Glu4fs
  • NP_203123.1:p.Glu4fs
  • LRG_329t1:c.10_17del
  • LRG_329:g.5077_5084del
  • LRG_329p1:p.Glu4fs
  • NC_000003.11:g.8775569_8775576del
  • NC_000003.11:g.8775572_8775579del
  • NC_000003.12:g.8733883_8733890delGCAGAAGA
  • NM_033337.2:c.10_17del
  • NM_033337.2:c.10_17delGAAGAGCA
Protein change:
E4fs
Links:
dbSNP: rs778914298
NCBI 1000 Genomes Browser:
rs778914298
Molecular consequence:
  • NM_001234.5:c.10_17del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_033337.3:c.10_17del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002752216Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Dec 16, 2021)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Ambry Genetics, SCV002752216.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The c.10_17delGAAGAGCA variant, located in coding exon 1 of the CAV3 gene, results from a deletion of 8 nucleotides at nucleotide positions 10 to 17, causing a translational frameshift with a predicted alternate stop codon (p.E4Hfs*17). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Although truncating variants have been implicated in autosomal recessive caveolinopathy, loss of function has not been established as a mechanism of disease for autosomal dominant caveolinopathy (Müller JS et al. Neuromuscul Disord, 2006 Jul;16:432-6; Ueyama H et al. Neuromuscul Disord, 2007 Jul;17:558-61; Traverso M et al. J Neurol Neurosurg Psychiatry, 2008 Jun;79:735-7). Based on the supporting evidence, this variant is expected to be pathogenic for autosomal recessive caveolinopathy when present along with a second pathogenic variant on the other allele; however, the clinical significance of this variant in the heterozygous state is unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024